stars 1 stars 2 stars 3

A leading provider of 3D bioprinting and microscopy services in Eastern and Central Europe. A Cellink 3D bioprinters distributor. Sygnis Bio Technologies expertise: - Nanolive cell 3D super-resolution imaging - PALM/dSTORM/SIM super-resolution tabletop microscopy - Extrusion based, single cell, DLP and holographic 3D bioprinting - Micropatterning and biopatterning

Sygnis Bio Technologies Questions

Andrzej Burgs is the 공동 CEO of Sygnis Bio Technologies.

13 people are employed at Sygnis Bio Technologies.

G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users